dolasetron mesylate
Sponsors
Gary Morrow, University of Southern California, Vanderbilt University
Conditions
Malignant Digestive System NeoplasmNausea and VomitingPostoperative Nausea and VomitingUnspecified Adult Solid Tumor, Protocol Specific
Phase 2
Phase 3
Unknown Phase
Dolasetron Mesylate and Dexamethasone With or Without Aprepitant in Preventing Nausea and Vomiting in Patients Undergoing Oxaliplatin-Containing Chemotherapy for Gastrointestinal Malignancy
TerminatedNCT02550119
Start: 2006-04-19End: 2010-04-01Updated: 2017-03-28
Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis
CompletedNCT02625181
Start: 2016-07-31End: 2017-11-30Updated: 2019-03-07